Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational safety study of Priligy or alternate care in men with premature ejaculation
2009-011309-18Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dapoxetine in premature ejaculation (PE) (2 cohorts), sponsored by Janssen Pharmaceutical. Primary endpoints: Safety profile of Priligy in clinical practice and Orthostatic reaction history or positive orthostatic test among patients selected for Priligy. Started Nov 2009; status: completed.
02
Drugs
dapoxetine
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on 2009-011309-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011309-18.